Set point regulation of astrocyte intracellular Ca2+signalling by Taynnan Barros, Michael & Dey, Subhrakanti
Set Point Regulation of Astrocyte Intracellular Ca2+ Signalling
Michael Taynnan Barros1 and Subhrakanti Dey2
Abstract— Neurodegenerative diseases are the cur-
rent centre of attention in medicine due to their
increased physiological and psychological burden on
the ageing society and in the other hand the lack of
efficient treatment to them. In parallel, nanotechnol-
ogy opens possibilities to study neurodegeneration in
the molecular level and uncover cellular properties
at the nanoscale that possibly allow disease control
using novel system biology methods. The communi-
cation between neurons and astrocytes explains how
a failure in their communication impact neuronal
activity, and how the intracellular Ca2+ signalling of
astrocytes can interfere in the synaptic quality. This
paper presents a theoretical investigation of a feed-
forward and feedback control technique to regulate
the quantity of IP3 that determines the concentration
of Ca2+ emitted from intracellular signalling. The
analysis of the control model showed that the quantity
of Ca2+ signalling can be stabilised at a desired level. A
potential application is to facilitate the Ca2+ concen-
tration around this desired level to maintain cellular
homoeostasis for longer periods of time, which can
lead to a technology for preventing neurodegenerative
diseases. The proposed approach can result in novel
solutions for both nanobiology and nanomedicine de-
velopment, where synthetic biology can be used to
program the control functionality into the cells. Other
ways of implementing such technology are also ex-
plored, including nanoparticles, implantable devices
and molecular communications.
I. Introduction
Neurodegenerative diseases cause progressive, incapac-
itating cognitive, behavioural, and motor dysfunction [1].
In Europe, 35% of all disease burden is due to brain
disorders [2], and depressive disorders are the single
biggest source of disability in the high-income countries,
and the third worldwide [3]. They are related to the qual-
ity of synapses in neuronal communications. The poor
concentration of glutamate inside the synaptic channel
will lead to the wrong propagation of the synapses,
causing symptoms of most neurodegenerative diseases
like lack of memory, insomnia and depression. Current
treatment techniques of neurodegenerative diseases are
limited to drugs that are not effective as they only help
to eliminate symptoms, but not treat the disease and
indeed are far away from achieving their cure.
Recently, nanotechnology has gained attention for the
novel techniques that have emerged for treating diseases
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as well as neurodegeneration. Nanoparticles, control the-
ory, synthetic biology and molecular communications are
examples of such techniques that result in a targeted,
optimised, mobile and reliable drug or gene therapies
[4], [5]. This collection of techniques enables advanced
disease treatment by accessing the molecular level of cells
or tissues, which requires an understanding of certain
cellular properties as well as their regulation.
The evident control of Ca2+ levels in astrocytes en-
ables the indirect uptake of the glutamate release for
improvement of the synaptic transmission [6], [7]. The
first encountered challenge is to provide a theoretical
approach for realising the possibility of controlling the
astrocytes’ Ca2+ concentration and, therefore, create a
mathematical framework that will form the basis for
potential alternative approaches to preventing neurode-
generative diseases.
For this purpose, the cytosolic Ca2+ is the focus of this
study. Moreover, internal Ca2+ signalling is characterised
by oscillations invoked by a particular range of IP3.
The elimination of such oscillatory behaviour will give
a stable level of the desired Ca2+ concentration. The
IP3 is then a decisive factor for Ca2+ regulation, in
which its increase is controlled by a constant factor,
β. A mathematical model captures this dependent be-
haviour that enables control of the intracellular Ca2+
signalling by regulating IP3 levels. This mathematical
model is based on the feed-forward and feedback con-
trol mechanism to perform indirect astrocytes’ cytosolic
Ca2+ concentration regulation. Since proteins are more
easily stimulated, IP3 is then used as a starting point
where its control will lead to the accurate stimulation of
Ca2+ ions [8], [9]. On the other hand, the control function
needs to be simple enough to be implemented in nano-
scale settings, and therefore the model is developed upon
needs to account only for the most important system
characteristics.
The contributions of this paper are:
• Control of IP3-induced Ca2+ oscillations. The
mathematical model shows how a desired stable level
of Ca2+ is achieved by removing the oscillation of
the Ca2+. The model also shows robustness over
different Ca2+ signal patterns.
• Review of implementation techniques of the
control function. Even though this paper remains
in the theoretical domain, a study of possible imple-
mentation techniques that enables the control to be
achieved both in-vitro and in-vivo are explored and
include nanoparticles, synthetic biology, implantable
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Fig. 1: Intracellular Ca2+ signalling model for astrocytes. The
flux/efflux rates control the concentration of Ca2+ signalling.
The function σ1 models the Ca2+-induced Ca2+ release
(CICR). The function σ2 denotes the leakage of Ca2+ ions to
the cytosol from the sarco(endo)plasmic reticum (SERCA),
and the function σ3 denotes the efflux of Ca2+ from the
sarco(endo)plasmic reticulum to the endoplasmic reticulum.
devices and molecular communications.
The rest of this paper is organized as follows. Mathe-
matical modelling of astrocytes intracellular Ca2+ sig-
nalling is presented in §II, followed by the problem
statement, §III, and the feed-forward feedback control in
§IV. The results and analysis are presented in §V. The
methodologies for potential implementation in-vitro and
in-vivo are finally discussed in §VI followed by concluding
remarks in §VII.
II. Astrocyte Intracellular Ca2+ Signalling
The intracellular Ca2+ signalling model in astrocytes
consists of state equations for the Ca2+ concentration
in the cytosol (C) (Eq. 1), kinetics of IP3 receptors (h)
(Eq. 2) as well as the IP3 concentration (I) (Eq. 3). This
model is proposed in [10], and a visual illustration of the
model is presented in Fig. 1. The main state equations
are defined as follows:
dC
dt
= σ1 + σ2 − σ3, (1)
dh
dt
=
H − h
τ
, (2)
dI
dt
=
1
α
(i0 − I) + βH(E0 − 35) (3)
where α is the degradation time constant of IP3 con-
centration, i0 is the IP3 concentration in equilibrium,
β is the production rate of IP3 ions, E0 is the pre-
synaptic potential and H(.) is the Heaviside function.
Ca2+-induced Ca2+ release (CICR) is the trigger process
of Ca2+ ions from the sarco(endo)plasmic reticulum by
existing Ca2+ ions within the cytosol. The quantities H, τ
are defined in (8), (9, (10). The function σ1 models the
CICR and is defined as:
σ1 = vm
3h3[c0 − (1 + C1)C] (4)
where v is the maximal CICR rate, c0 is the total cell-free
Ca2+ concentration depending on the cytosol volume,
and C1 is the ratio between the cytosol and endoplasmic
reticulum volume.
The IP3 and Ca2+ ion binding process responsible for
providing stable IP3 kinetics are represented as:
m =
(
I
I + d
)(
C
C + d3
)
(5)
where d is the IP3 dissociation constant and d3 is the
Ca2+ activation-dissociation constant.
The function σ2 denotes the leakage of Ca2+ ions to
the cytosol from the sarco(endo)plasmic reticum and is
represented as:
σ2 = v1[c0 − (1 + C1)C] (6)
where v1 is the maximal rate of Ca2+ ions leakage from
the endoplasmic reticulum.
The efflux of Ca2+ from the sarco(endo)plasmic retic-
ulum to the endoplasmic reticulum (SERCA) is repre-
sented as:
σ3 =
v2C
2
k2 + C2
(7)
where v2 is the maximal rate of SERCA uptake, and k
is Ca2+ binding affinity.
The following equations are important for modelling
h:
H =
Q
Q+ C
(8)
τ =
1
a(Q+ C)
(9)
Q =
I + d
I + d2
d1 (10)
where d1 is the Ca2+ inactivation dissociation constant,
d2 is the IP3 dissociation constant and a is the IP3
receptors binding rate for Ca2+ inhibition.
III. Problem Statement
Regulating Ca2+ levels in astrocytes can indirectly
control the glutamate release and potentially improve the
synaptic transmission in neuronal communication. The
main challenge is to provide an analysis of the astrocytes’
Ca2+ concentration and, therefore, create a theoretical
framework that can be developed towards future ap-
proaches to preventing neurodegenerative diseases.
For this purpose, the problem of controlling levels of
Ca2+ in the cytosol is investigated in this paper. More
specifically, internal Ca2+ signalling is characterised by
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Fig. 2: Ca2+ oscillation with respect to time. In this illustra-
tion the IP3 = 0.5 μM. The Ca2+ concentration (C - blue
line) oscillates alongside with the kinetics of IP3 receptors (h
- dashed yellow line).
oscillations invoked by a certain range of IP3. Fig 2
shows the Ca2+ oscillation at IP3 = 0.5 μM and when
production rate of IP3 ions (β - eqn. 3) varies from 0.1-
1.5 μM/s. The elimination of such oscillatory behaviour
(both of the Ca2+ oscillation (blue line) and the kinetics
of the IP3 oscillation (dashed yellow line)) will give a
stable level of the desired Ca2+ concentration.
Fig 3 shows how the IP3 can affect the intracellular
Ca2+ signalling. An increase of IP3 in the system is
desired for regular Ca2+ concentration levels. Since β is
responsible for the IP3 increase, it is highly important
for regulation of Ca2+ concentration levels. As soon as
IP3 becomes constant, the Ca2+ concentration will drop.
The electrical component of the astrocytes also plays
an important role (E0 from Eq. 3). However, since the
synapses happen periodically, we are interested in the
design of control within one period when the synapses
are activated.
The IP3 is then a decisive factor for Ca2+ regulation,
in which its increase is controlled by β. Such behaviour is
going to be further explored with a mathematical model
that enables the intracellular Ca2+ signalling control by
regulating IP3 levels.
IV. Feed-forward and Feedback Control of
Intracellular Ca2+ Signalling in Astrocytes
Before proceeding further, we assume for the rest of the
paper that H(E0 − 35) = 1. Note that for other values
of the Heaviside function (such as H(E0 − 35) = 12 ), a
similar analysis can be applied. By denoting the column
vector state x = [C h I]′, we can rewrite (1), (2), (3) as
the following nonlienar controlled state space system
dx
dt
= f(x) +Bu (11)
where f(x) = [f1(x) f2(x) f3(x)]′, and f1(.) = σ1+σ2+
σ3, f2(.) =
H−h
τ , and f3(.) =
1
α (i0− I), and B = [0 0 1]′.
The control variable u represents the state feedback and
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Fig. 3: Effect of both IP3 and the E0 on the Ca2+ concen-
tration. The Ca2+ concentration is highly dependent on the
increasing factor of IP3 and, therefore, so is the stability.
feedforward based IP3 regulation parameter given by (see
also [9]):
β = βf −Kf (C − Cf ), (12)
where βf is the feedforward control representing the
desired IP3 level If , Cf is the associated desired Ca2+
concentration level and Kf is the linear feedback gain.
Note that although not visible in the above equation,
there is an associated value of h as well, which is denoted
by hf . Denote the entire associated state vector as xf =
[Cf hf If ]
′. Then it follows that
dxf
dt
= f(xf ) +Buf (13)
where of course, uf = βf . Here, the measured output is
the Ca2+ concentration level, so that at the desired level,
the output is given by h¯(xf ) = Cf .
Remark 1: Note that without loss of generality, one
can assume that in the uncontrolled case, i.e., when
β = 0, there is an equilibrium point at the origin for
the nonlinear dynamical system dxdt = f(x) [9], implying
f(0) = 0. This fact will be used in the stability analysis
of the system when the control law (12) is applied in a
subsequent subsection.
A. βf and Cf Relationship
To obtain the required regulation factor βf for a de-
sired Cf , this paper presents a mathematical relationship
between βf and Cf as follows. Suppose there is an
equilibrium point (in the controlled case when β > 0) at
(ho co I0), then dhdt = 0 at h = ho and
dC
dt = 0 at C = co,
and dIdt = 0 for I = I0. Rewriting Eq. 1 and Eq. 2 we can
compute Io, from for Eq. 3, (since H(E0 − 35) = 1). As
t → ∞, I becomes a constant Io, which is represented as
Io = (i0+αβ). This relationship enables the computation
of the control function (12).
317
TABLE I: Simulation parameters for astrocytes.
Variable Value
v 6s−1
v1 0.11 s−1
c0 2.0μM
C1 0.185
v2 0.9 Ms−1
k 0.1μM
d 0.13μM
d1 1.049 s−1
d2 0.9434μM/s
d3 0.08234μM
a 0.2 s−1
α 1/0.00014μM
i0 0.160μM
β 0.1-1.5μM
E0 35
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Fig. 4: Elimination of Ca2+ oscillation using the proposed
feedback and feed-forward control technique. Regular Ca2+
oscillations C (solid lines) is compared to a controlled Ca2+
level C∗ (dashed line) for IP3 = 0.5 (μM).
V. Analysis
We now present an analysis of the proposed regula-
tion of Ca2+ concentration levels for astrocytes. This
is divided into four parts for a proper understanding
of the system and also quantification of the application
impact if this control technique is utilised. First, we
start by showing how the control system will eliminate
intracellular Ca2+ oscillations in astrocytes, solving the
problem defined in Section III. This is followed by the
disturbance analysis, where Gaussian noise is applied
to the intracellular Ca2+ signalling for adding a con-
trolled abnormal behaviour to the system and observing
system effectiveness while looking at the feed-forward
and feedback techniques separately. Finally, analyses of
the envisioned applications of disease prevention are
shown, which consist of three scenarios (i) elimination
of oscillatory behaviour (ii) robustness over frequency
modulation (iii) robustness over post-synaptic influence.
A total elimination of the Ca2+ oscillation is obtained
using the proposed mechanism, and this is illustrated in
Fig 4. The Eq. 12, which represents the state feedback
and feed-forward control, can efficiently adjust β accord-
ingly and maintain Ca2+ concentration levels throughout
the period shown, by solving Eqs. 1, 2 and 3. For the
control technique, we replace the β in Eq. 3 by Eq. 12, in
order to integrate the feed-forward and feedback control
element to the system. We chose a value of Cf = 0.32
μM , which is a mean value of the system and compute
the desired βf with an appropriate calibration of the Kf .
This positive result demonstrates the effectiveness and
potential of utilising the control technique to stabilise
the excessive Ca2+ concentration that may lead to neu-
rodegenerative diseases.
Two other scenarios were investigated with the objec-
tive of analysing different Ca2+ signal patterns. First,
frequency modulation can be achieved by saddle-node
homoclinic bifurcation [11], and implemented also in
the model by changing the IP3 concentration to higher
levels, Fig 5. Second, astrocytes also receive membrane
voltage signals from post-synaptic neurons that change
the Ca2+ behaviour [12], Fig 6. These signals are also
simulated abstractly mimicking the same behaviour in
this scenario. The control mechanism shows the high level
of robustness for presenting the same performance even
with different signal patterns of Ca2+. This shows the
importance IP3 levels in the Ca2+ intracellular signalling,
and how controlling such protein is impacting in also
controlling the Ca2+ behaviour.
VI. Methodologies for implementation in-vitro
and in-vivo
The theoretical approach used in this paper is not
directly linked to a particular implementation technique
in systems biology. In this section, we present a discussion
on different possibilities for implementing the proposed
control system in both in-vitro and in-vivo settings.
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Fig. 5: Elimination of Ca2+ oscillation using the proposed
feedback and feed-forward control technique now with fre-
quency modulation by IP3 increase. Regular Ca2+ oscillations
C (solid lines) is compared to a controlled Ca2+ level C∗
(dashed line) for IP3 = 1.0 (μM).
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Fig. 6: Elimination of Ca2+ oscillation using the proposed
feedback and feed-forward control technique now with influ-
ence from a post-synaptic neuron. Regular Ca2+ oscillations
C (solid lines) is compared to a controlled Ca2+ level C∗
(dashed line) for IP3 = 0.5 (μM).
A. Nanoparticles
Nanoparticles have been already used in systems bi-
ology for predicting toxicity at the cellular level by
measuring the modulation changes in intracellular Ca2+
signals. The mere presence of toxicity does not inhibit
their applicability to biology due to existing techniques of
decreasing toxicity and also the numerous potential ben-
efits of their usage. Nanoparticles are known to bypass
existing biological protection systems of living organisms
to perform desired tasks including, attachment to cancer-
ous cells, bypassing the blood-brain barrier, etc. Control
of Ca2+ can be also be achieved with nanoparticles,
which include: Carbon Black (CB), Titanium Dioxide
(T iO2) or Zinc Oxide (ZnO) [13]. These nanoparticles
are known to stimulate the IP3 channels and influence
the amplification of Ca2+ signals through the endoplas-
mic reticulum. However, this technique is also known
for stressing cellular organelles and therefore causing
cell death over time. Researchers are concentrating their
efforts in determining which stress signalling pathways
are induced downstream of nanoparticle exposure.
B. Synthetic Biology
Synthetic biology is paving the way for advancements
in systems biology by allowing programmability of living
organisms and extending their functionalities based on
a particular application [14]. Synthetic biology can also
program cellular signalling pathways with a particular
gene expression that can change how molecules interact
inside a cell. This can be considered a building block
for advanced systems, in which the signalling pathways
can include basic logic operation with an integration of
logic circuits, that takes into account molecular levels
of the cell to perform computation tasks. Controlling
Ca2+ signalling pathways is another alternative solution
towards implementing the presented control function.
The gene expression can be changed to make the IP3 con-
centration change adaptively based on the Ca2+ concen-
tration through independent excitatory and inhibitory
pathways. In this way, both very high and very low
level of Ca2+ can be re-arranged to normal homoeostasis
levels. The primary challenge is to perform this task
distributively and with precision in particular cells. For
this, targeted gene therapy has recently gained more
attention due to the recent results, that also include
regeneration of cellular functions in the brain, see for
example [15].
C. Implantable Devices
Advancements in nanotechnology are enabling
nanoscale devices with biocompatible materials to be
implanted in numerous locations in in-vivo organisms
with the challenge of regulating cellular activity.
These devices use photostimulation to activate distinct
pathways in synthetic cells, namely neuron dust [16].
The main advantage of such technology is the ability of
accurately maintaining time-sensitive channels at stable
levels, and in this case, the control of post-synaptic
neurons by neuron dust devices would contribute to the
regulation of Ca2+ signalling in astrocytes. The major
drawback is the necessity of enabling cells to be photo-
sensitive, which is a current research topic for neuron
rehabilitation techniques combining photostimulation
with targeted gene therapy solutions.
D. Molecular Communications and Nanonetworks
Molecular communications is a recent research area
responsible for designing communication systems to ac-
tuate in-vivo but at the same time trying to not affect
the existing biological processes [4], [17]. These tasks can
be very challenging due to the usage of few biological
channels to send information, and therefore, limiting the
molecular communications system performance based on
this high correlation with biological systems regulation
functions. Addressing this drawback is a current research
theme in the community, and researchers have suggested
the use of silence communication techniques [18]. But
this property can also be used to influence cellular sig-
nalling pathways in various degrees. A nanonetwork can
be employed for communicating cells through molecular
communications channels, with the receiving end being
a targeted cell. This mechanism has been used to predict
cellular properties in [19], [20], where the process is
inverted to regulate the underlying Ca2+ molecular com-
munication system. In this particular case, the receiver
cell will have specific stimuli to start the regulation
of intracellular signalling. The major challenge is to
accurately send information over tissues due to the high
influence of noise in biological communication channels
[21].
VII. Conclusion
New approaches for possibly treating neurodegenera-
tive diseases are appealing to address the low efficiency
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of current methods. With the advancements in nan-
otechnology, now one can think of also controlling Ca2+
signalling in astrocytes for regulating gliotransmitters’
concentration and indirectly control synaptic quality. A
theoretical control theory approach is presented in this
paper, where cellular state information such as Ca2+
concentration and IP3 concentration are used in a control
function that measures the proper amount needed for
ultimately regulating Ca2+ at the desired level. These
results lead to an exploratory discussion surrounding
the future possibilities in implementing such approach,
including nanoparticles, synthetic biology, implantable
devices and molecular communications. Further research
work needs to be carried out in both stability and
disturbance analysis of this system, and also regarding
how to deal with noise in intracellular environments.
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